{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03973",
    "Peptide Name": "HH973 (synthetic AMPs, Trp-rich; XXA, UCLL1c)",
    "Source": "Amino acid substitution of indolicidin, bovine cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FIKWKFRWWKWR",
    "Sequence Length": 12,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Rich",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 2.19,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "58%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (64.29%) toIndolicidin analog HH972W: 33%.Activity: active against P. aeruginosa PAO1 (MIC 8 ug/ml), E. coli (MIC 4 ug/ml), S. typhimurium (MIC 8 ug/ml), S. aureus (MIC 4 ug/ml), S. epidermidis (MIC 2 ug/ml), E. faecalis ATCC29212 (MIC 8 ug/ml), and C. albicans (MIC 8 ug/ml). It is the most active one in this indolicidin variants.",
    "Author": "Hancock RE, Hilpert K, Cherkasov A, Fjell C.2006",
    "Reference": "Patent US9017656",
    "Title": "SMALL CATIONIC ANTIMICROBIAL peptides"
  },
  "3D Structure": []
}